The week in industry: FDA approves the first treatment for children with Lambert-Easton myasthenic syndrome
This week: Drug manufacturers are now required to disclose drug prices on TV ads, Medicines Discovery Catapult (Cheshire, UK) and LifeArc (London, UK) partner to identify and develop novel biomarkers and the European Commission approves the use of PALYNZIQ® to treat Phenylketonuria.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>